NASDAQ | ETF
The fund will, under normal circumstances, invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of small- and mid-sized capitalization ("small/mid cap") companies selected for their growth potential.
For purposes of the 80% policy, the fund's managers consider small/mid cap companies to be those whose market capitalization falls within the 12-month range of the Russell 2500TM Growth Index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| APP | Applovin Corp | Technology | Software - Application | 9.47% |
| RGEN | Repligen Corporation | Healthcare | Medical Instruments & Supplies | 3.25% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.18% |
| SWAV | Shockwave Medical Inc | Healthcare | Medical Devices | 3.08% |
| SCCO | Southern Copper Corporation | Basic Materials | Copper | 2.99% |
| WLK | Westlake Chemical Corporation | Basic Materials | Specialty Chemicals | 2.77% |
| HEI | Heico Corporation | Industrials | Aerospace & Defense | 2.60% |
| SOFI | SoFi Technologies Inc. | Financial Services | Credit Services | 2.40% |
| STRL | Sterling Construction Company Inc | Industrials | Engineering & Construction | 2.39% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.31% |
| NRG | NRG Energy Inc. | Utilities | Utilities - Independent Power Producers | 2.27% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.26% |
| MANH | Manhattan Associates Inc | Technology | Software - Application | 2.26% |
| ONTO | Onto Innovation Inc | Technology | Semiconductor Equipment & Materials | 2.24% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 2.17% |
| BSY | Bentley Systems Inc | Technology | Software - Application | 2.15% |
| HAS | Hasbro Inc | Consumer Cyclical | Leisure | 2.13% |
| EQH | Axa Equitable Holdings Inc | Financial Services | Asset Management | 2.13% |
| CNM | Core & Main Inc | Industrials | Industrial Distribution | 2.12% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.07% |